These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32281447)

  • 41. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity?
    Candia L; Marquez J; Hernandez C; Zea AH; Espinoza LR
    J Rheumatol; 2007 Feb; 34(2):374-9. PubMed ID: 17183618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of Toll-like Receptor 2 and Toll-like Receptor 4 in Tuberculous Pleural Effusion.
    Lin Y; Feng T; Lan J; Chen C; Qin Z; Wu Y; Shi H; Ye J; Wei C; Wang W; Huang L
    Med Chem; 2017; 13(6):569-576. PubMed ID: 28494727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Leukocyte toll-like receptor expression in pathergy positive and negative Behçet's disease patients.
    van der Houwen TB; Dik WA; Goeijenbier M; Hayat M; Nagtzaam NMA; van Hagen M; van Laar JAM
    Rheumatology (Oxford); 2020 Dec; 59(12):3971-3979. PubMed ID: 32756992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toll-like receptor 2 and 9 expression on circulating neutrophils is associated with increased mortality in critically ill patients.
    Lenz M; Draxler DF; Zhang C; Kassem M; Kastl SP; Niessner A; Huber K; Wojta J; Heinz G; Speidl WS; Krychtiuk KA
    Shock; 2020 Jul; 54(1):35-43. PubMed ID: 31688663
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased Toll-Like Receptor 2 and Toll-Like Receptor 7/8-Induced Cytokines in Parkinson's Disease Patients.
    da Silva DJ; Borges AF; Souza PO; de Souza PR; Cardoso CR; Dorta ML; de Oliveira MA; Teixeira AL; Ribeiro-Dias F
    Neuroimmunomodulation; 2016; 23(1):58-66. PubMed ID: 26886382
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toll-Like Receptors-2 and -4 in Graves' Disease-Key Players or Bystanders?
    Polak A; Grywalska E; Klatka J; Roliński J; Matyjaszek-Matuszek B; Klatka M
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554206
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptors TLR-2, TLR-4, TLR-7, and TLR-9 in tumor tissue and serum of the patients with esophageal squamous cell carcinoma and gastro-esophageal junction cancer.
    Diakowska D; Nienartowicz M; Grabowski K; Rosińczuk J; Krzystek-Korpacka M
    Adv Clin Exp Med; 2019 Apr; 28(4):515-522. PubMed ID: 29968427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced Platelet Toll-like Receptor 2 and 4 Expression in Acute Coronary Syndrome and Stable Angina Pectoris.
    Gurses KM; Kocyigit D; Yalcin MU; Canpinar H; Oto MA; Ozer N; Tokgozoglu L; Guc D; Aytemir K
    Am J Cardiol; 2015 Dec; 116(11):1666-71. PubMed ID: 26455385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Insulin infusion suppresses while glucose infusion induces Toll-like receptors and high-mobility group-B1 protein expression in mononuclear cells of type 1 diabetes patients.
    Dandona P; Ghanim H; Green K; Sia CL; Abuaysheh S; Kuhadiya N; Batra M; Dhindsa S; Chaudhuri A
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E810-8. PubMed ID: 23403945
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toll-like receptor expression on classic and pro-inflammatory blood monocytes after acute exercise in humans.
    Simpson RJ; McFarlin BK; McSporran C; Spielmann G; ó Hartaigh B; Guy K
    Brain Behav Immun; 2009 Feb; 23(2):232-9. PubMed ID: 18930806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fulminant type 1 diabetes mellitus exhibits distinct clinical and autoimmunity features from classical type 1 diabetes mellitus in Chinese.
    Zheng C; Zhou Z; Yang L; Lin J; Huang G; Li X; Zhou W; Wang X; Liu Z
    Diabetes Metab Res Rev; 2011 Jan; 27(1):70-8. PubMed ID: 21218510
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increased Expression of Toll-Like Receptors 2 and 4 in Renal Transplant Recipients that Develop Allograft Dysfunction: A Cohort Study.
    Hosseinzadeh M; Nafar M; Ahmadpoor P; Noorbakhsh F; Yekaninejad MS; Niknam MH; Amirzargar A
    Iran J Immunol; 2017 Mar; 14(1):24-34. PubMed ID: 28341816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists.
    Lacerte P; Brunet A; Egarnes B; Duchêne B; Brown JP; Gosselin J
    Arthritis Res Ther; 2016 Jan; 18():10. PubMed ID: 26759164
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TLR2 stimulation impairs anti-inflammatory activity of M2-like macrophages, generating a chimeric M1/M2 phenotype.
    Quero L; Hanser E; Manigold T; Tiaden AN; Kyburz D
    Arthritis Res Ther; 2017 Nov; 19(1):245. PubMed ID: 29096690
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toll-like receptors 2 and 4 expression on peripheral blood lymphocytes and neutrophils of Egyptian multiple sclerosis patients.
    Labib DA; Ashmawy I; Elmazny A; Helmy H; Ismail RS
    Int J Neurosci; 2022 Apr; 132(4):323-327. PubMed ID: 32842834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice.
    Aumeunier A; Grela F; Ramadan A; Pham Van L; Bardel E; Gomez Alcala A; Jeannin P; Akira S; Bach JF; Thieblemont N
    PLoS One; 2010 Jul; 5(7):e11484. PubMed ID: 20628601
    [TBL] [Abstract][Full Text] [Related]  

  • 58. FAMILY HISTORY OF DIABETES IS ASSOCIATED WITH INCREASED RISK OF RECURRENT DIABETIC KETOACIDOSIS IN PEDIATRIC PATIENTS.
    Vakharia JD; Agrawal S; Molino J; Topor LS
    Endocr Pract; 2020 Mar; 26(3):305-311. PubMed ID: 31859553
    [No Abstract]   [Full Text] [Related]  

  • 59. Expression of Toll-like receptors by neonatal leukocytes.
    Dasari P; Zola H; Nicholson IC
    Pediatr Allergy Immunol; 2011 Mar; 22(2):221-8. PubMed ID: 21054549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tissue factor and Toll-like receptor (TLR)4 in hyperglycaemia-hyperinsulinaemia. Effects in healthy subjects, and type 1 and type 2 diabetes mellitus.
    Singh A; Boden G; Rao AK
    Thromb Haemost; 2015 Apr; 113(4):750-8. PubMed ID: 25653143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.